Volume 104, Issue 2 pp. 258-265

The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells

Nicoletta Bianchi

Nicoletta Bianchi

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Fabio Osti

Fabio Osti

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Cristina Rutigliano

Cristina Rutigliano

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Federica Ginanni Corradini

Federica Ginanni Corradini

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Elena Borsetti

Elena Borsetti

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Marina Tomassetti

Marina Tomassetti

Biotechnology Centre, University of Ferrara, Ferrara, Italy

Search for more papers by this author
Carlo Mischiati

Carlo Mischiati

Department of Biochemistry and Molecular Biology,

Search for more papers by this author
Giordana Feriotto

Giordana Feriotto

Biotechnology Centre, University of Ferrara, Ferrara, Italy

Search for more papers by this author
Roberto Gambari

Roberto Gambari

Department of Biochemistry and Molecular Biology,

Biotechnology Centre, University of Ferrara, Ferrara, Italy

Search for more papers by this author
First published: 25 December 2001
Citations: 68
Professor Roberto Gambari, Department of Biochemistry and Molecular Biology, Via L. Borsari 46, 44100 Ferrara, Italy.

Abstract

The human leukaemic K562 cell line can be induced in vitro to undergo erythroid differentiation by a variety of chemical compounds, including haemin, butyric acid, 5-azacytidine and cytosine arabinoside. Differentiation of K562 cells is associated with an increased expression of embryo-fetal globin genes, such as the ζ, ε and γ globin genes. Therefore the K562 cell line has been proposed as a useful in vitro model system to determine the therapeutic potential of new differentiating compounds as well as to study the molecular mechanism(s) regulating changes in the expression of embryonic and fetal human globin genes. Inducers of erythroid differentiation which stimulate γ-globin synthesis could be considered for possible use in the experimental therapy of those haematological diseases associated with a failure in the expression of adult β-globin genes. In this paper we demonstrated that the G + C selective DNA-binding drugs chromomycin and mithramycin were powerful inducers of erythroid differentiation of K562 cells. Erythroid differentiation was associated with an increase in the accumulation of (a) Hb Gower 1 and Hb Portland and (b) γ-globin mRNA.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.